ANTIMICROBIAL RESISTANCE TRENDS IN WOUND PATHOGENS: A STUDY AT A TERTIARY CARE HOSPITAL IN PESHAWAR, PAKISTAN

Main Article Content

Shahid Ahmad
Amina Farrukh Alavi
Dr. Madeeha Minhas
Asma Javid
Hafiz Aamir Ali Kharl

Keywords

Wound infection, Bacteria, MDR, Staphylococcus aureus, Bacterial pathogens, Pakistan

Abstract

Objective: This study aimed to investigate prevalent bacterial pathogens causing wound infections
and their antibiotic resistance patterns among patients at a Tertiary care hospital in Peshawar, Pakistan.
The primary focus was to identify geographic-specific resistance trends and clinical implications for
effective management strategies.
Methodology: Samples collected from patients presenting with microbiological infection signs at
Tertiary care hospital from February 23rd, 2022, to August 23rd, 2023, included 243 plus specimens.
The selection of Peshawar as the study site factored in its geographical specificity, potentially
impacting bacterial prevalence and resistance patterns. The collection utilized cotton swabs, and
subsequent processing employed the streak plate method and inoculation onto Blood agar, chocolate
agar, and MacConkey agar for optimal bacterial growth. Microbiological assays and specialized tests
were performed, including Triple Sugar Iron (TSI) Test, Motility Indole Urease (MIU) Test, Simmons
Citrate Test, Bile Esculin Agar, Catalase Test, Coagulase Test, Oxidase Test, and Antibiotic
Susceptibility Test via disc diffusion method.
Results: Analysis revealed prevalent pathogens: Staphylococcus aureus (30%), Escherichia coli
(24%), Pseudomonas (24%), Klebsiella spp. (10%), Streptococcus (4%), Proteus spp. (3%),
Acinetobacter spp. (3%), and Enterococcus (2%). Notably, Gram-positive bacteria displayed
resistance to Cephalosporins but sensitivity to Carbapenems. Conversely, Gram-negative bacteria
exhibited substantial antibiotic resistance. Antibiotic Resistance: The study found high resistance rates
in Staph. aureus (92% to Cefixime and 94% to Ceftazidime). One potential reason for the increased
antibiotic resistance observed, as indicated in this study, could be the overuse or inappropriate use of
antibiotics.


Conclusion: Our study highlights the need for specific strategies to reduce antibiotic resistance in pus
samples. Resistance percentages and prevalence statistics, analyzed, have yielded significant findings.
These findings underscore the critical need for tailored treatments, stringent antibiotic management,
and coordinated policy actions

Abstract 270 | PDF Downloads 91

References

1. World Health Organization (2016) Global action plan on antimicrobial resistance. Antimicrobial Resistance Division (AMR), National Action Plans and Monitoring and Evaluation (NPM).
2. Alam, M.M. et al. (2019) “Antimicrobial Resistance Crisis and Combating Approaches,” Journal of Medicine, 20(1), pp. 38–45. Available at: https://doi.org/10.3329/jom.v20i1.38842.
3. Bouki, C., Venieri, D. and Diamadopoulos, E. (2013) “Detection and fate of antibiotic resistant bacteria in wastewater treatment plants: A review,” Ecotoxicology and Environmental Safety, 91, pp. 1–9. Available at: https://doi.org/10.1016/j.ecoenv.2013.01.016.
4. folkhalsomyndigheten Public Health Agency of Sweden (2020) Swedish work on containment of antibiotic resistance.
5. French, G.L. (2010) “The continuing crisis in antibiotic resistance,” International Journal of Antimicrobial Agents, 36, pp. S3–S7. Available at: https://doi.org/10.1016/S0924-8579(10)70003-0.
6. Government of the Netherlands (no date) International cooperation on antibiotic resistance.
7. J V, S. et al. (2020) “Bacteriological profile of pus samples and their antibiotic susceptibility pattern,” Indian Journal of Microbiology Research, 7(1), pp. 43–47. Available at: https://doi.org/10.18231/j.ijmr.2020.010.
8. Kohanski, M.A., Dwyer, D.J. and Collins, J.J. (2010) “How antibiotics kill bacteria: from targets to networks,” Nature Reviews Microbiology, 8(6), pp. 423–435. Available at: https://doi.org/10.1038/nrmicro2333.
9. Llor, C. and Cots, J.M. (2009) “The Sale of Antibiotics without Prescription in Pharmacies in Catalonia, Spain,” Clinical Infectious Diseases, 48(10), pp. 1345–1349. Available at: https://doi.org/10.1086/598183.
10. Moges, F. et al. (2014) “The growing challenges of antibacterial drug resistance in Ethiopia,” Journal of Global Antimicrobial Resistance, 2(3), pp. 148–154. Available at: https://doi.org/10.1016/j.jgar.2014.02.004.
11. R. A., S. et al. (2012) “Antibiotic Resistance Profile of Gram Positive Bacteria Isolated from Wound Infections in Minna, Bida, Kontagora and Suleja Area of Niger State,” International JOURNAL OF HEALTH SCIENCE, 2(3), pp. 19–22. Available at: https://doi.org/10.5923/j.health.20120203.01.
12. Roca, I. et al. (2015) “The global threat of antimicrobial resistance: science for intervention,” New Microbes and New Infections, 6, pp. 22–29. Available at: https://doi.org/10.1016/j.nmni.2015.02.007.
13. Sakeena, M.H.F., Bennett, A.A. and McLachlan, A.J. (2018) “Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review,” International Journal of Antimicrobial Agents, 52(6), pp. 771–782. Available at: https://doi.org/10.1016/j.ijantimicag.2018.09.022.
14. Shahidullah, M. et al. (2012) “Antibiotic Sensitivity Pattern of Bacterial Isolates from Different Clinical Specimens: Experience at NICVD, Dhaka,” Cardiovascular Journal, 5(1), pp. 67–72. Available at: https://doi.org/10.3329/cardio.v5i1.12276.
15. Tenover, F.C. (2006) “Mechanisms of antimicrobial resistance in bacteria,” American Journal of Infection Control, 34(5), pp. S3–S10. Available at: https://doi.org/10.1016/j.ajic.2006.05.219.
16. World Health Organization (2014) Antimicrobial resistance: global report on surveillance.

Most read articles by the same author(s)